Comparison of glucagon levels in type­-1, type­-2-­diabetes and healthy subjects

Completed

• Conditions: Healthy individuals; E10.9; E11.9

• Registration Number: DRKS00022061
• Lead Sponsor: Medizinische Universität Graz, Universitätsklinik für Innere Medizin, Klinische Abteilung für Endokrinologie und Diabetologie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2016-05-03
• Study Start: 2020-06-12
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

1. Male or female, aged 18-90 years (both inclusive);
2. Diagnosed with type 1 diabetes or type 2 diabetes;

For healthy study participants:
1. Male or female, aged 18-90 years (both inclusive)

Exclusion Criteria

1. Any disorder, except for conditions associated with diabetes, which in the investigator’s opinion might jeopardise subject’s safety or results.

For healthy study participants: 1. Diabetes mellitus or known conditions that affect glucagon concentration like Roux-en-Y-Gastric bypass, vagotomy or renal failure.

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The aim of the study was to determine fasting glucagon values ??of individuals with type 1 diabetes and type 2 diabetes in comparison to healthy study participants.

Secondary Outcome Measures

Name	Time	Method
Comparison of two glucagon analysis methods in healthy people and in individuals with type 1 diabetes and type 2 diabetes.